July 27, 2017

I am always challenged and intellectually stimulated when I feel as though I’ve identified a pattern, practice, or even consequence of doing business that reveals itself as I observe the fledgling industry that we’ve alchemized and branded here in the U.S. as our versi...

July 11, 2017

Throughout the week of August 7th, I have visits in DC with top policymakers and regulators, politicians, stem cell industry leaders, researchers and CBER officials. We specialize in guiding providers wishing to conduct RMAT-Designated trials.

Please reload

Recent Posts
Please reload

Please reload

Search By Tags
Follow Us
  • Twitter Basic Square
  • LinkedIn Social Icon
Featured Posts

Regenerative Outcomes, LLC, Achieves Rapid Growth, as Demand for RMAT Consultancy Expands – Interview with Megan Moneypenny, CEO

May 1, 2019

Please reload


+1 (855) FDA-RMAT

P.O. Box 40211, Nashville, TN 37204

© 2017 Regenerative Outcomes, LLC.   All Rights Reserved.